Candidate ALS therapeutics motor toward "in vitro clinical trials"

Yong Jun Kim; Gabsang Lee

doi:10.1016/j.stem.2013.05.009

Candidate ALS therapeutics motor toward "in vitro clinical trials"

Yong Jun Kim
, Gabsang Lee

Research output: Contribution to journal › Short survey › peer-review

8 Citations (Scopus)

Abstract

Conducting drug discovery efforts in patient- and disease-specific cells can maximize their likelihood of success. In this issue of Cell Stem Cell, Yang et al. (2013) demonstrate the power of lineage-specific cell-based drug screens by identifying a compound that promotes survival of stem-cell-derived ALS mutant motor neurons.

Original language	English
Pages (from-to)	633-634
Number of pages	2
Journal	Cell Stem Cell
Volume	12
Issue number	6
DOIs	https://doi.org/10.1016/j.stem.2013.05.009
Publication status	Published - 6 Jun 2013

Access to Document

10.1016/j.stem.2013.05.009

Cite this

@article{f4121b54867646bab4aa8b0950c1a343,

title = "Candidate ALS therapeutics motor toward {"}in vitro clinical trials{"}",

abstract = "Conducting drug discovery efforts in patient- and disease-specific cells can maximize their likelihood of success. In this issue of Cell Stem Cell, Yang et al. (2013) demonstrate the power of lineage-specific cell-based drug screens by identifying a compound that promotes survival of stem-cell-derived ALS mutant motor neurons.",

author = "Kim, \{Yong Jun\} and Gabsang Lee",

year = "2013",

month = jun,

day = "6",

doi = "10.1016/j.stem.2013.05.009",

language = "English",

volume = "12",

pages = "633--634",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - Candidate ALS therapeutics motor toward "in vitro clinical trials"

AU - Kim, Yong Jun

AU - Lee, Gabsang

PY - 2013/6/6

Y1 - 2013/6/6

N2 - Conducting drug discovery efforts in patient- and disease-specific cells can maximize their likelihood of success. In this issue of Cell Stem Cell, Yang et al. (2013) demonstrate the power of lineage-specific cell-based drug screens by identifying a compound that promotes survival of stem-cell-derived ALS mutant motor neurons.

AB - Conducting drug discovery efforts in patient- and disease-specific cells can maximize their likelihood of success. In this issue of Cell Stem Cell, Yang et al. (2013) demonstrate the power of lineage-specific cell-based drug screens by identifying a compound that promotes survival of stem-cell-derived ALS mutant motor neurons.

UR - https://www.scopus.com/pages/publications/84878839731

U2 - 10.1016/j.stem.2013.05.009

DO - 10.1016/j.stem.2013.05.009

M3 - Short survey

C2 - 23746968

AN - SCOPUS:84878839731

SN - 1934-5909

VL - 12

SP - 633

EP - 634

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 6

ER -

Candidate ALS therapeutics motor toward "in vitro clinical trials"

Abstract

Access to Document

Other files and links

Fingerprint

Cite this